Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1974 1
1979 1
1980 1
1981 2
1983 1
1984 1
1987 1
1990 1
1991 1
1994 1
1995 1
1996 1
1997 1
1998 2
1999 1
2000 1
2001 1
2008 1
2011 1
2014 2
2015 4
2016 9
2017 4
2018 9
2019 14
2020 13
2021 4
2022 12
2023 12
2024 6
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Kowal-Bielecka O, Riccardi A, Distler O; EUSTAR collaborators. Hoffmann-Vold AM, et al. Ann Rheum Dis. 2021 Feb;80(2):219-227. doi: 10.1136/annrheumdis-2020-217455. Epub 2020 Sep 28. Ann Rheum Dis. 2021. PMID: 32988845 Free PMC article.
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation.
Siegert E, Biesen R, Dzamukova M, Furth C, Probst M, Doellinger F, Walter-Rittel T, Fleischmann A, Wilhelm A, Beenken AE, Wiebe E, Pecher AC, Henes J, Florian S, Simon D, Kleyer A, Burmester GR, Keller U, Krönke J, Krönke G, Alexander T. Siegert E, et al. Ann Rheum Dis. 2025 Apr;84(4):653-656. doi: 10.1016/j.ard.2025.01.043. Epub 2025 Feb 24. Ann Rheum Dis. 2025. PMID: 40000264 No abstract available.
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y; EUSTAR collaborators. Lescoat A, et al. Among authors: siegert e. JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729. JAMA Dermatol. 2023. PMID: 37378994 Free PMC article.
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.
Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y. Valentini G, et al. Among authors: siegert e. Ann Rheum Dis. 2017 Jan;76(1):270-276. doi: 10.1136/annrheumdis-2016-209768. Epub 2016 Sep 12. Ann Rheum Dis. 2017. PMID: 27621285
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis.
Albach FN, Minopoulou I, Wilhelm A, Biesen R, Kleyer A, Wiebe E, Fleischmann A, Frick M, Damm F, Gogolok J, Serve S, Locher BN, Borie D, Casteleyn V, Siegert E, Dörner T, Alexander T, Furth C, Zernicke J, Movassaghi K, Hütter-Krönke ML, Schrezenmeier E, Schneider U, Bullinger L, Krönke G, Penack O, Simon D. Albach FN, et al. Among authors: siegert e. Rheumatology (Oxford). 2025 Jun 1;64(6):4075-4077. doi: 10.1093/rheumatology/keaf077. Rheumatology (Oxford). 2025. PMID: 39928370 No abstract available.
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.
Yan Q, Bruni C, Garaiman A, Mihai C, Jordan S, Becker MO, Elhai M, Dobrota R, Liubov P, Henes J, Hachulla E, Siegert E, Balbir-Gurman A, Cuomo G, Riemekasten G, Heitmann S, Beigi DMR, Ullman S, Sfikakis P, Ingegnoli F, Bernardino V, Truchetet ME, Vonk M, Galdo FD, Hoffmann-Vold AM, Shuang Y, Distler O; EUSTAR collaborators. Yan Q, et al. Among authors: siegert e. Ann Rheum Dis. 2025 Apr;84(4):620-631. doi: 10.1016/j.ard.2025.01.014. Epub 2025 Feb 1. Ann Rheum Dis. 2025. PMID: 39894689
Functional autoantibodies in systemic sclerosis.
Günther J, Rademacher J, van Laar JM, Siegert E, Riemekasten G. Günther J, et al. Among authors: siegert e. Semin Immunopathol. 2015 Sep;37(5):529-42. doi: 10.1007/s00281-015-0513-5. Epub 2015 Aug 21. Semin Immunopathol. 2015. PMID: 26292621 Review.
[Pulmonary fibrosis in rheumatic diseases].
Grund D, Siegert E. Grund D, et al. Among authors: siegert e. Internist (Berl). 2018 Sep;59(9):911-920. doi: 10.1007/s00108-018-0480-8. Internist (Berl). 2018. PMID: 30094614 Review. German.
[Peripheral nerve involvement in rheumatic diseases].
Casteleyn V, Hahn K, Stenzel W, Siegert E. Casteleyn V, et al. Among authors: siegert e. Z Rheumatol. 2019 May;78(4):339-351. doi: 10.1007/s00393-019-0621-z. Z Rheumatol. 2019. PMID: 30944998 Review. German.
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.
Wyss A, Jordan S, Graf N, Carreira PE, Distler J, Cerinic MM, Siegert E, Henes J, Zanatta E, Riccieri V, Truchetet ME, Oksel F, Li M, Kucharz EJ, Eyerich K, Del Galdo F, Vonk MC, Vold AH, Gabrielli A, Distler O; EUSTAR collaborators. Wyss A, et al. Among authors: siegert e. Arthritis Res Ther. 2024 Oct 31;26(1):187. doi: 10.1186/s13075-024-03418-2. Arthritis Res Ther. 2024. PMID: 39482761 Free PMC article.
112 results